Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN

Sievers, Quinlan L., Petzold, Georg, Bunker, Richard D., Renneville, Aline, Słabicki, Mikołaj, Liddicoat, Brian J., Abdulrahman, Wassim, Mikkelsen, Tarjei, Ebert, Benjamin L., Thomä, Nicolas H.·2018·Science
DOI 10.1126/science.aat0572

Cited by (525)

Items 401–500 of 525

  1. Bumped pomalidomide-based PROTACs
    Huijuan Guo · 2024 · Communications Chemistry
  2. Identification of small molecule agonists of fetal hemoglobin expression for the treatment of sickle cell disease
    Jian-Ping Yang, Rachel Toughiri, Anshu P. Gounder, Dan Scheibe, Matt J. Petrus, Sarah J. Fink, Sébastien Vallée, Jon A. Kenniston, Nikolaos Papaioannou, Steven Langston et al. · 2024 · PLoS ONE
  3. Structure-guided design of a truncated heterobivalent chemical probe degrader of IRE1α
    Breanna L. Zerfas, Yingpeng Liu, Jianwei Che, Katherine A. Donovan, John M. Hatcher, Fidel Huerta, Rebecca J. Metivier, Radosław P. Nowak, Leah Ragosta, Tiffany Tsang et al. · 2025 · RSC Medicinal Chemistry
  4. Native mass spectrometry for proximity-inducing compounds: a new opportunity for studying chemical-induced protein modulation
    Emanuele Fabbrizi, Francesco Fiorentino, Fabrizio Casano, Antonello Mai, Dante Rotili · 2025 · Expert Opinion on Drug Discovery
  5. ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC
    Nathan L. Tran, Jiewei Jiang, Min Ma, Gillian E. Gadbois, Kevin Christian Montecillo Gulay, Alyssa L. Verano, Haowen Zhou, Chun‐Teng Huang, David A. Scott, Anne G. Bang et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Unraveling the Engagement of Kinases to CRBN Through a Shared Structural Motif to Optimize PROTACs Efficacy
    Serena Rosignoli, Sara Giordani, Maddalena Pacelli, Giulia Guarguaglini, Alessandro Paiardini · 2025 · Biomolecules
  7. Facile and Practical Synthesis of Substituted Piperidine‐2,6‐Diones Under Transition‐Metal Free Condition
    Yuehua Liu, Zhang‐Qin Xue, Kai‐Wen Yang, Hao‐Wen Yin, Bo Yang, Rui Zhang, Hao Zhong, Zhushuang Bai · 2025 · ChemistryOpen
  8. Rifamycin O as a novel CRBN ligand for targeted degradation of IKZF1/3 proteins in hematopoietic malignancies
    Liang Liao, Qiang Wang, Zhipeng Gao · 2025 · Acta Pharmaceutica Sinica B
  9. Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma
    Chad C. Bjorklund, Marta Larráyoz, Jian Kang, Hsiling Chiu, Natasha Shtraizent, Lei Wu, Shirong Li, Chih-Chao Hsu, Junfei Zhao, Michael D. Amatangelo et al. · 2025 · Blood Neoplasia
  10. Leveraging Targeted Protein Degradation for G Protein-Coupled Receptors: The Development of CCR2 Molecular Degraders
    Khaled Essa, Natalia V. Ortiz Zacarı́as, Sascha Röth, Bo‐Tao Xin, Sabine de Winter, Cas van der Horst, Bente T.M. Bleijs, Richard A. de Heiden, Rodanthi Voulgaraki, Elsa Neubert et al. · 2025 · Journal of Medicinal Chemistry
  11. Reinforced molecular dynamics: Physics-infused generative machine learning model simulates protein motion
    István Kolossváry · 2026 · PNAS Nexus
  12. ProxiCapture reveals context-dependent CRBN interactome landscape of molecular glue degraders
    Rubina S. Kazi, H. Bailey, Jan Gerhartz, Varun Jayeshkumar Shah, Betül Toker, Julia Bein, Peter Johannes Wild, Radosław P. Nowak, Thorsten Mosler, Ivan Đikić · 2026 · Disease and Therapeutics
  13. Enabling Access to sp 3 ‐Enriched Targeted Protein Degraders via Redox‐Neutral Radical Cross‐Coupling
    Philipp Neigenfind, Clara Gathmann, Emily C. Cherney · 2026 · Angewandte Chemie
  14. Enabling Access to sp 3 ‐Enriched Targeted Protein Degraders via Redox‐Neutral Radical Cross‐Coupling
    Philipp Neigenfind, Clara Gathmann, Emily C. Cherney · 2026 · Angewandte Chemie International Edition
  15. Discovery and Mechanistic Elucidation of NQO1‐Bioactivatable Small Molecules That Overcome Resistance to Degraders
    Bárbara M. G. Barbosa, Aikaterini Sfyaki, Sergi Rafael, Ferran José‐Duran, Joan Pous, Carolina Sánchez, Carles Perez‐Lopez, Mar Vilanova, Marko Cigler, Marina Gay et al. · 2023 · Angewandte Chemie
  16. Archaeal NusA2 is the ancestor of ribosomal protein eS7 in eukaryotes
    Duy Khanh Phung, Simona Pilotto, Dorota Matelska, Fabian Blombach, Nikos Pinotsis, Ladislav Hovan, Francesco Luigi Gervasio, Finn Werner · 2024 · Structure
  17. Small-molecule degron mimetics for targeted protein degradation
    Xingui Liu · 2025 · Essays in Biochemistry
  18. Neural crest induction requires SALL4-mediated BAF recruitment to lineage specific enhancers
    Demurtas, Martina, Barnada, Samantha M., van Domselaar, Emma, Mitchell, Zoe H., Deelen, Laura, Trizzino, Marco · 2025 · Development
  19. Possible New Candidates Involved to Thalidomide-Related Limbs and Cardiac Defects: A Systems Biology Approach
    Bruna Duarte Rengel, Lavínia Schüler‐Faccini, Lucas Rosa Fraga, Fernanda Sales Luiz Vianna, Thayne Woycinck Kowalski · 2024 · Biochemical Genetics
  20. Development of photo-lenalidomide for cellular target identification
    Zhi Lin, Yuka Amako, Farah Kabir · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Cereblon controls the timing of muscle differentiation in Ciona embryos
    Juanjuan Long, Andrea Mariossi, Cao Chen · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Photoswitchable Molecular Glues Enable Optical Control of Transcription Factor Degradation
    Christopher J. Arp, Martin Reynders, Vedagopuram Sreekanth, Praveen Kokkonda, Michele Pagano, Amit Choudhary, Dirk H. Trauner · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  23. ZNF276 and WIZ are CRBN neosubstrates involved in the anti-angiogenic activity of thalidomide and immunomodulatory drugs
    Takumi Ito, Tomoko Asatsuma‐Okumura, Akinori Endo, Junichi Yamamoto, Yoshiko Iwai, Yuki Yamaguchi, Mikihiko Naito, Hiroshi Handa, Yasushi Saeki · 2023 · Research Square
  24. Rational Design of Molecular Glues: Breakthroughs and Perspectives
    Juzeng An, Xiaojun Zhang · 2024 · ChemRxiv
  25. Engineering CRBN for rapid identification of next generation binders
    H. Bailey, Jonathan Eisert, Joshua Vollrath, Eva-Maria Leibrock, Ivan S. Kondratov, Tetiana Matviiuk, Nataliya A. Tolmachova, Julian D. Langer, Ansgar A. Wegener, F.J. Sorrell et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Thalidomide – From a Banned Drug to Molecular Glues, PROTACs, and New Concepts in Drug Discovery
    Junichi Yamamoto, Hiroshi Handa, Yuki Yamaguchi · 2024 · Wiley eBooks
  27. A Cryptic Interfacial Pocket Uncovered in Full CRL4 CRBN –IKZF3 Ubiquitylation Complex Enhances IMiD Efficacy
    Zhiheng Deng, Huasong Ai, Qiang Shi, Jiawei Liang, Zaozhen He, Jiqing Zheng, Haoxiang Li, Liying Zhang, Wei He, Shixian Tao et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Developing potent and selective TBK1 molecular glue degraders for cancer immunotherapy
    John Caldwell, Patrick R. A. Zanon, Iona Ferguson, Stephen T. Hallett, Tencho Tenev, Natalia Serrano-Aparicio, Russell J.H. Wood, Shakil Khan, Sidonie Wicky John, Rebecca Wilson et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Principles of prevention and management of adverse events of immunomodulatory drugs in the treatment of multiple myeloma
    Grzegorz Charliński, David H. Vesole, Artur J. Jurczyszyn · 2022 · Nowotwory Journal of Oncology
  30. Clues for glues: from serendipity to nature’s blueprints in degrader discovery
    Zuzanna Kozicka · 2025 · Essays in Biochemistry
  31. Sculpting Cell Fate: The Expanding Universe of Nondegradative Proximity‐Inducing Tools
    Hangdi Xiao, Lan Wang, Mengxiao Chen, Tengfei Zhen, Yao Chen, Haopeng Sun · 2026 · ChemMedChem
  32. PROTAC-mediated multi-target protein degradation in Alzheimer's disease: mechanistic insights, therapeutic applications, and translational challenges
    Bin Wang, Yunan Li, Tingting Yao, Xinai Shen, Huan Li, Wei Jiang, Xinuo Li, Zheying Zhu · 2026 · RSC Medicinal Chemistry
  33. GlueFinder: A Data-Driven Framework for the Rational Discovery of Molecular Glues
    Jeffrey Skolnick, Bharath Srinivasan, Hongyi Zhou · 2026 · Journal of Chemical Information and Modeling
  34. A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader
    Monica C. Rodrigo-Brenni, Jasper C. Komen, Ghaith M. Hamza, Natacha Bohin, Tomas Adomavicius, Angelo Andres, Stefan Blaho, Ulf Börjesson, Gavin W. Collie, Gian Marco De Donatis et al. · 2026 · Nature Communications
  35. Synthetic and Medicinal Chemistry Perspectives on Cereblon‐Binding Molecular Glue Degraders: Recent Advances and Emerging Trends
    Hyuck-Jae Won, Seung Mok Baek, Min Hoo Lee, Jae Hyeon Park, Jeong‐Won Shin, Yo‐Sep Yang, Yoon Hu Jang, Kyung‐Soo Inn, Nam‐Jung Kim · 2026 · European Journal of Organic Chemistry
  36. A Scalable, Direct‐to‐Biology Platform for Accelerated Discovery of Cereblon‐Based Molecular Glue Degraders
    Jia‐Yu Wang, Guang‐Liang Yin, Yijia Chi, Yuan‐Peng Feng, Chu‐Cheng Zhou, Hui‐Jun Nie, Zhi‐Gao Zhang, Shuting Meng, Yang Chen, Zhi‐Peng Zhou et al. · 2026 · Angewandte Chemie International Edition
  37. The molecular basis for nuclear pore destruction by a proximity-inducing molecular glue
    Stephen M. Hinshaw, Linjie Yuan, Md Abdullah Al Noman, Michael J. Martinez, Gianna M. Colombo, Brendan G. Dwyer, Wenzhi Ji, Bryan A. Romero, Ines Forrest, Joey Lu et al. · 2026 · Cell chemical biology
  38. Proteomics‐Driven Strategies for Proximity‐Inducing Drug Discovery
    Rufeng Fan, Jiahui Ni, Tiantian Zhou, H Q Jiang, Wensi Zhao, Minjia Tan · 2026 · Angewandte Chemie International Edition
  39. On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases
    Janik Weckesser, Nebojša Miletić, Saran Aswathaman Sivashanmugam, Uli Ohmayer, Martin Steger, Bachuki Shashikadze, Paul Gehrtz, Andrea Unzue Lopez, Ansgar A. Wegener, T J Dietz et al. · 2026 · Journal of Medicinal Chemistry
  40. Zinc Finger Proteins as Regulators of Organ Fibrosis
    Bootsakorn Boonkaew, Wirawit Srivongtrakul, Chaiyaboot Ariyachet · 2026 · Journal of Cellular Biochemistry
  41. DCAF11-dependent molecular glue degrader activated by glutathionylation
    Hojong Yoon, Franziska Wachter, Katharine Barrett, Cyrus Jin, Anna Rodríguez-Pöhnlein, Justine C. Rutter, Ryan J. Lumpkin, Rebecca J. Metivier, Katherine A. Donovan, Kheewoong Baek et al. · 2026 · Nature
  42. Proteome-wide identification of the druggable CRBN interactome
    Pius Galli, Shuhao Xiao, Yanxiang Meng, Alexander Hanzl, Alexandra M. Bendel, Regina Baur, Jacob D. Aguirre, Anna M. Díaz-Rovira, Maximilian R. Stammnitz, Georg Kempf et al. · 2026 · Nature Biotechnology
  43. Targeted Protein Degradation Chemical Probes
    Carles Galdeano, Xavier Barril · 2020 · Royal Society of Chemistry eBooks
  44. A deep dive into degrader-induced protein-protein interfaces
    Pius Galli, Carlos Pla‐Prats, Nicolas H. Thomä · 2023 · Trends in Pharmacological Sciences
  45. A master erythroid regulator gets its own GPS
    Lily Jun-shen Huang, James J. Bieker · 2020 · Blood
  46. Structural and Biophysical Principles of Degrader Ternary Complexes
    David Zollman, Alessio Ciulli · 2020 · Royal Society of Chemistry eBooks
  47. Med Chem Remote: The Frontiers in Medicinal Chemistry 2021
    Fabian H. Knaup, Christian Meyners, Anna Charalampidou, Patryk Krajczy, Patrick L. Purder, Tatjana Ross, Felix Hausch · 2021 · ChemMedChem
  48. Proteolysis-targeting chimeras (PROTACs) as novel biotechnology for cancer therapy
    Ota Fuchs · 2022 · Elsevier eBooks
  49. Chromatin accessibility combined with enhancer clusters activation mediates heterogeneous response to dexamethasone in myeloma cells
    Victor Gaborit, Jonathan Cruard, Catherine Guérin‐Charbonnel, Jennifer Derrien, Jean-Baptiste Alberge, Elise Douillard, Nathalie Roi, Magali Devic, L. Campion, Frank Westermann et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  50. History of IMiDs and Protein Degradation as a Pharmacological Modality
    Junichi Yamamoto, Tomoko Asatsuma‐Okumura, Takumi Ito, Yuki Yamaguchi, Hiroshi Handa · 2022 · Wiley eBooks
  51. Rational Design of Molecular Glues: Breakthroughs and Perspectives
    Juzeng An, Xiaojun Zhang · 2023 · ChemRxiv
  52. Molecular glue degraders enhance CAPRIN1-dependent lysosomal degradation of APP in Alzheimer’s disease
    Sung Han Jung, Raktim N. Roy, Xu Wang, Bin Liu, Nancy Jaiswal, Ratan K. Rai, Yuichiro Takagi, Cen Gao, Li‐Fan Zeng, Ho-Yin Lo et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Modeling the Structures of Ternary Complexes Mediated by Molecular Glues
    Michael L. Drummond · 2024 · Wiley eBooks
  54. Reinforced molecular dynamics: Physics-infused generative machine learning model explores CRBN activation process
    István Kolossváry, Rory Coffey · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Visible-Light-Controlled Residue-Selective Cross-Linking for Deciphering Protein Complexes and Dynamic Protein-Protein Interactions in Live Cells
    Yali Xu, Hao Hu, Yu Ran, Wensi Zhao, An‐Di Guo, Hui‐Jun Nie, Linhui Zhai, Guang-Liang Yin, Jintao Cheng, Shengna Tao et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Rewiring the fusion oncoprotein EWS/FLI1 in Ewing sarcoma with bivalent small molecules
    Michael J. Bond, Ryan P. Golden, Giulia DiGiovanni, Briana Howard, Roman C. Sarott, Basel A. Karim, Sai P. Gourisankar, Gabriela Alexe, Kenneth N. Ross, Nathanael S. Gray et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  57. A cell-based degrader assessment platform facilitates discovery of functional NUDT5 PROTACs
    Seher Alam, Maria Joao Almeida A Silva Pires, Gabriel Tidestav, Ann‐Sofie Jemth, Julia Eklund, Fredrik Klingegård, Rémi Caraballo, Massimiliano Gaetani, Dante Rotili, Siebe van den Elzen et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Regulation of BCL11A DNA binding and expression in human erythrocyte precursor HUDEP-2 cells
    Meigen Yu, Puspa Das, John R. Horton, Jujun Zhou, J. Jack Lee, Tingting Hong, Yue Lu, Marcos R. Estecio, Polina A. Iakova, Abhinav K. Jain et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  59. New Activities of CELMoDs, Cereblon E3 Ligase-modulating Drugs
    Mary E. Matyskiela, Thomas Clayton, Joel W. Thompson, Christopher W. Carroll, Leslie A. Bateman, Laurie A. LeBrun, Philip P. Chamberlain · 2020 · Royal Society of Chemistry eBooks
  60. ZNF48 and ZNF84 are potentially involved in the regulation of genes affected by thalidomide
    Thayne Woycinck Kowalski, Ágata de Vargas Dupont, Lucas Rosa Fraga · 2021 · Reproductive Toxicology
  61. Cancer Targets Involving the Ubiquitin Proteasome System
    Erika M. V. Araujo · 2021 · Wiley eBooks
  62. "El soneto a Granada" de Pablo Antonio Cuadrado
    Nicasio Urbina · 2010 · Hispanic poetry review
  63. Faculty Opinions recommendation of Major Advances in Targeted Protein Degradation: PROTACs, LYTACs, and MADTACs.
    John A. Lowe III · 2021 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  64. Faculty Opinions recommendation of Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15.
    Ning Zheng · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  65. Faculty Opinions recommendation of Rational discovery of molecular glue degraders via scalable chemical profiling.
    Stevan W. Djurić · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  66. Faculty Opinions recommendation of The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K.
    Mark A. Dawson · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  67. IKZF3 amplification frequently occurs in HER2 positive breast cancer and is a potential therapeutic target
    Chih-Yi Lin, Chung-Jen Yu, Chia‐I Shen · 2022 · Research Square
  68. A Structural and Biophysical Perspective of Degrader Activity Through Ternary Complex Formation
    Morgan S. Gadd, Marine C. Aublette · 2022 · Wiley eBooks
  69. Life mimics art
    Muthukumaran Venkatachalapathy, Craig M. Crews · 2023 · Cell Research
  70. Research progress in small-molecule modulators of protein-protein interactions
    Bin Yang, Xiangbing Qi · 2023 · Chinese Science Bulletin (Chinese Version)
  71. Modulation of HSF1 activity by p53 and its impact in cancer therapies
    Tamara Isermann · 2023 · eDiss (Georg-August-Universität Göttingen)
  72. Ikzf1 association with Foxp3 for Foxp3-dependent gene repression in Treg cells: induction of autoimmunity and tumor immunity by disrupting the association
    Kenji Ichiyama, Jia Long, Yusuke Kobayashi, Yuji Horita, Takeshi Kinoshita, Yamami Nakamura, Chizuko Kominami, Katia Georgopoulos, Shimon Sakaguchi · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  73. SMALL-MOLECULE DEGRADERS OF IKAROS ZINC FINGER (IKZF) TRANSCRIPTION FACTORS
    Natalie Holmberg‐Douglas, Hunter P. Shunatona, Godwin K. Kumi, Ashok V. Purandare · 2023 · Medicinal chemistry reviews
  74. Simple and Efficient Synthesis of Piperidine-2,6-Diones
    Yuehua Liu, Zhang‐Qin Xue, Kai-Wen Yang, Hao‐Wen Yin, Tian‐Zhang Wang, Yu‐Qiu Guan, Yu-Feng Ligang, Hao Zhong, Zhushuang Bai · 2023 · SSRN Electronic Journal
  75. A Review of the Immunomodulatory Activity of Novel Drug Iberdomide (CC-220) for Multiple Myeloma
    Sherlyn Anne Cardenas, Cristina Jaida Cosio, S.J. Lee, Faith Joy Domingo, Donna Rose Gido, Alexander Johann Lim, Jacqueline Abiso-Padilla · 2023 · International Journal of Research Publication and Reviews
  76. Mechanistic Basis and Role of Immunomodulatory Drugs
    John G. Gribben · 2024 · Wiley eBooks
  77. Inducing or Enhancing Protein-Protein Interaction to Develop Drugs: Molecular Glues with Various Biological Activity
    Rongyu Zhang, Yirong Zheng, Fengjiao Xiang · 2024 · SSRN Electronic Journal
  78. Novedades en la inmunoterapia de las enfermedades autoinmunes del tejido conectivo. Parte I: lupus eritematoso cutáneo
    Isabel Bielsa Marsol · 2024 · Piel
  79. Targeted protein degradation using thalidomide and its derivatives
    Satoshi Yamanaka · 2024 · Translational and Regulatory Sciences
  80. Cullin-RING ligase BioE3 reveals molecular-glue-induced neosubstrates and rewiring of the endogenous Cereblon ubiquitome
    Laura Merino‐Cacho, Orhi Barroso‐Gomila, Mónica Pozo-Rodríguez, Veronica Muratore, Claudia Guinea-Pérez, Álvaro Serrano‐Morrás, Coralia Pérez, Sandra Cano-López, Ainhoa Urcullu, Mikel Azkargorta et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Research Progress of IMiDs as PPI Stabilizer in Protein Degradation
    冰茹 宋 · 2025 · Hans Journal of Medicinal Chemistry
  82. Targeted Protein Degradation of Metalloenzymes
    Conor O’Herin, Seth M. Cohen · 2025 · Wiley eBooks
  83. Melting KRAS resistance
    Shatha AbuHammad, Mikolaj Michal Slabicki · 2025 · Nature Chemical Biology
  84. Sticky business: Rationalizing CRBN’s zinc-finger targeting by molecular glues
    Jonathan W. Bushman, Patrick Ryan Potts · 2025 · Molecular Cell
  85. Molecular Glues as Activators for PPI
    Xiangbing Qi · 2025 · Wiley eBooks
  86. Progress on molecular glue degraders
    Jiaqi Chen, Zhiheng Deng, Haoxiang Li, Lei Liu · 2025 · Scientia Sinica Chimica
  87. Tricarbonyl Rhenium‐Based PROTACs Degrade the SARS‐CoV‐2 Mpro Protease
    Liuruiqi Luo, Yuxiang Lu, He Meng, Wenkai Lin, Kai Lu, Jing Wang, Jinghui Wang, Yufang Xiong, Zong‐Wan Mao, Wei Ting Xia · 2025 · Chemistry - A European Journal
  88. Mapping the latent CRBN-molecular glue degrader interactome
    Pius Galli, Shuhao Xiao, Yanxiang Meng, Alexander Hanzl, Alexandra M. Bendel, Jacob D. Aguirre, Anna M. Díaz-Rovira, Maximilian R. Stammnitz, Georg Kempf, Lukas Kater et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Discovery and Characterization of a First-In-Class HCK/BTK PROTAC DFCI-002-06 for the Treatment of MYD88 Mutated B Cell Malignancies
    John M. Hatcher, Shirong Liu, Amanda Kofides, Alexa G Canning, Dominic Pizzarella, X. Shirley Liu, Nickolas Tsakmaklis, Maria Luisa Guerrera, Christopher J. Patterson, Alberto Güijosa et al. · 2026 · Journal of Medicinal Chemistry
  90. Design synthesis and biological evaluation of novel BCL6/GSPT1 degrader as anti-DLBCL agent
    Rong Hu, Xia-Tong Hu, Ying-Yue Yang, Lingfeng Du, X. LAN, Peng Luo, Cai-Hua Li, Luo-Ting. YU, Ningyu Wang · 2026 · European Journal of Medicinal Chemistry
  91. An Integrative Computational Biophysical Workflow for Molecular Glue Discovery
    Musheng Wang, Danial Muhammad, Wei Xia, Jiali Leng, Zheng Lei, Zhaoxi Sun, John Z.H. Zhang · 2026 · Journal of Computational Biophysics and Chemistry
  92. Synthesis and biological evaluation of Retro-2-based PROTACs reveal PEG-linker length and warhead impact on GSPT1 degradation
    Marine Michon, Sébastien Curpanen, Ombeline Pessey, Robert Thaï, Jean‐Charles Gaillard, Gaëtan Herbette, Karen Hinsinger, Daniel Gillet, Jean Armengaud, Jean‐Christophe Cintrat et al. · 2026 · European Journal of Medicinal Chemistry
  93. Molecular Glue Degraders Redefining Targeted Therapies From Discovery to Therapeutic Applications
    Jiaye Wen, Jingtian Yu, Wuqiang Wen, Baishan Jiang · 2026 · MedComm – Oncology
  94. Leveraging High-Throughput Proteomics and AI-Based Protein Folding to Accelerate VAV1 Molecular Glue Discovery
    Jin Wang, Hanfeng Lin, Xin Yu et al. · 2026 · Research Square
  95. Indazolone-Based Molecular Glue Degraders as a Tunable Platform for Reprogramming Cereblon Substrate Specificity
    Hui‐Jun Nie, Jiamin Wang, Hao Xu, Yin-Jue Zhou, Guang‐Liang Yin, Xiaomim Xu, Gaoya Xu, Beijing Chen, Xian Li, Xiaobei Hu et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Cancer biology and the principles of targeted cancer drug discovery
    A. Davies, G. Jones, S. Krishnan, M. Krishnamoorthy, M. Maruggi, M. Kaneda, K. Marjon · 2026 · Elsevier eBooks
  97. Optimization of novel quinazolinone derivatives as CRBN E3 ligase modulators for enhanced degradative activity and metabolic stability
    Peng Chen, Hong Peng, Chen Liu, Yuxiang Li, Tong Yang, Mohan Li, Chengxuan Hu, Shaojie Li, Zihao Deng, Zhen Wang et al. · 2026 · Bioorganic Chemistry
  98. Overcoming breast cancer resistance through targeted protein degradation and next generation chimeras
    Xinyao Wang, Jiawen Song, Yuan Zhao, Wei Li, Junfeng Li, Xuefei Xu, Wenhong Liu, Fangfang Tao, Ye Xu · 2026 · Pharmacological Research
  99. Progress of structurally diverse cereblon (CRBN) ligands and their application in PROTAC degraders
    Shuguang Yang, Yanxin Zhang, Xiaoping Song, Qingchao Liu, Daidi Fan, Ying Xu · 2026 · Bioorganic Chemistry
  100. From Serendipity to Rationality: Expanding Druggability by Molecular Glue Discovery
    David E. Heppner, CongBao Kang, Weijun Xu · 2026 · Journal of Medicinal Chemistry